Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants-Reference-Cited by-同舟云学术

Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants

Published:2009-11-15 Issue:10 Volume:125 Page:2456-2464
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bigioni Mario,Parlani Massimo,Bressan Alessandro,Bellarosa Daniela,Rivoltini Licia,Animati Fabio,Crea Attilio,Bugianesi Rossana,Maggi Carlo Alberto,Manzini Stefano,Binaschi Monica

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference23 articles.

1. Advances in the non-surgical treatment of melanoma;Hersey;Expert Opin Investig Drugs,2002

2. Temozolomide for the treatment of metastatic melanoma: a systematic review;Quirt;Oncologist,2007

3. The chemoresistance of human malignant melanoma: an update;Serrone;Melanoma Res,1999

4. Apoptosis and melanoma chemoresistance;Soengas;Oncogene,2003

5. Systemic chemotherapy in the treatment of malignant melanoma;Lens;Expert Opin Pharmacother,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of Genetic Materials for the Management of Biological Disorders: Advancement and Roles of Polysaccharides and their Derivatives;Current Drug Delivery;2023-06

2. Natural polysaccharides for the delivery of anticancer therapeutics;Natural Polysaccharides in Drug Delivery and Biomedical Applications;2019

3. Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside;Advanced Science;2018-01-08

4. Polymer–drug conjugates;Drug Delivery in Oncology;2014-04

5. Population pharmacokinetic/pharmacodynamic modeling of drug-induced adverse effects of a novel homocamptothecin analog, elomotecan (BN80927), in a Phase I dose finding study in patients with advanced solid tumors;Cancer Chemotherapy and Pharmacology;2012-06-15